The board of directors (the "Board") of 3D Medicines Inc. announces that the address of the principal place of business of the Company in Hong Kong will be changed to 19th Floor, Golden Centre, 188 Des Voeux Road Central, Hong Kong with effect from 27 December 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.75 HKD | 0.00% | -1.89% | -11.65% |
Mar. 29 | 3D Medicines' 2023 Loss Almost Halves as Revenue Jumps 12% | MT |
Mar. 28 | 3D Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-11.65% | 196M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- 1244 Stock
- News 3D Medicines Inc.
- 3D Medicines Inc. Announces Change of Principal Place of Business in Hong Kong